Rohto Pharmaceutical Co (4527N) Q3 2022 Earnings Report
0 Followers
MX:4527N Q3 2022 EPS Results
- Actual EPS
- MXN 4.35
- Consensus EPS
- MXN 2.84
- Beat/Miss
- Beat by +MXN 1.51
- One Year Ago EPS
- MXN 3.18
MX:4527N Q3 2022 Revenue Results
- Actual Revenue
- MXN 7.75B
- Expected Revenue
- MXN 6.88B
- Beat/Miss
- Beat by +MXN 871.54M
- YoY Revenue Growth
- +24.43%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 02/13/2023
- Time
- TBA
- Conference Call
- Monday, February 13, 2023
MX:4527N Upcoming Earnings
Rohto Pharmaceutical Co's next earnings date is estimated for November 12, 2026, based on past reporting schedules.
Q3 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:4527N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 12, 2026 | 2026 (Q2) | 3.84- | 3.06 | ― | ― |
| Aug 06, 2026 | 2026 (Q1) | 4.685.54 | 6.12 | -9.50% (-0.58) | |
| May 13, 2026 | 2025 (Q4) | 3.573.10 | 3.22 | -3.54% (-0.11) | |
| Feb 12, 2026 | 2025 (Q3) | 5.185.53 | 6.12 | -9.71% (-0.59) | |
| Nov 13, 2025 | 2025 (Q2) | 2.943.06 | 2.29 | 33.76% (+0.77) | |
| Aug 06, 2025 | 2025 (Q1) | ―6.12 | 4.37 | 40.10% (+1.75) | |
| May 13, 2025 | 2024 (Q4) | 2.933.22 | 2.46 | 30.69% (+0.76) | |
| Feb 12, 2025 | 2024 (Q3) | 5.776.12 | 4.93 | 24.26% (+1.20) | |
| Nov 13, 2024 | 2024 (Q2) | 4.122.29 | 3.86 | -40.83% (-1.58) | |
| Aug 07, 2024 | 2024 (Q1) | 4.694.37 | 4.68 | -6.70% (-0.31) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
